Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Effect of autologous transplantation of bone marrow cells concentrated with the MarrowXpress system in patients with critical limb ischemia.

Maione C, Botti C, Coppola CA, Silvestroni C, Lillo S, Schiavone V, Sica G, Sica V, Kumar V, Cobellis G.

Transplant Proc. 2013 Jan-Feb;45(1):402-6. doi: 10.1016/j.transproceed.2012.10.031.

PMID:
23375329
2.

A phase II trial of autologous transplantation of bone marrow stem cells for critical limb ischemia: results of the Naples and Pietra Ligure Evaluation of Stem Cells study.

Schiavetta A, Maione C, Botti C, Marino G, Lillo S, Garrone A, Lanza L, Pagliari S, Silvestroni A, Signoriello G, Sica V, Cobellis G.

Stem Cells Transl Med. 2012 Jul;1(7):572-8. doi: 10.5966/sctm.2012-0021. Epub 2012 Jul 6.

3.

Autologous bone marrow mononuclear cell therapy is safe and promotes amputation-free survival in patients with critical limb ischemia.

Murphy MP, Lawson JH, Rapp BM, Dalsing MC, Klein J, Wilson MG, Hutchins GD, March KL.

J Vasc Surg. 2011 Jun;53(6):1565-74.e1. doi: 10.1016/j.jvs.2011.01.074. Epub 2011 Apr 22.

4.

Early results and lessons learned from a multicenter, randomized, double-blind trial of bone marrow aspirate concentrate in critical limb ischemia.

Iafrati MD, Hallett JW, Geils G, Pearl G, Lumsden A, Peden E, Bandyk D, Vijayaraghava KS, Radhakrishnan R, Ascher E, Hingorani A, Roddy S.

J Vasc Surg. 2011 Dec;54(6):1650-8. doi: 10.1016/j.jvs.2011.06.118. Epub 2011 Oct 21.

5.

Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.

Powell RJ, Comerota AJ, Berceli SA, Guzman R, Henry TD, Tzeng E, Velazquez O, Marston WA, Bartel RL, Longcore A, Stern T, Watling S.

J Vasc Surg. 2011 Oct;54(4):1032-41. doi: 10.1016/j.jvs.2011.04.006. Epub 2011 Jul 31.

6.

Autologous intra-arterial infusion of bone marrow mononuclear cells in patients with critical leg ischemia.

Chochola M, Pytlík R, Kobylka P, Skalická L, Kideryová L, Beran S, Varejka P, Jirát S, Køivánek J, Aschermann M, Linhart A.

Int Angiol. 2008 Aug;27(4):281-90.

PMID:
18677289
7.

[A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].

Gu Y, Zhang J, Qi L.

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2006 Oct;20(10):1017-20. Chinese.

PMID:
17140078
8.
9.

Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.

Motukuru V, Suresh KR, Vivekanand V, Raj S, Girija KR.

J Vasc Surg. 2008 Dec;48(6 Suppl):53S-60S; discussion 60S. doi: 10.1016/j.jvs.2008.09.005.

10.
11.

Transplantation of autologous bone marrow mononuclear cells for patients with lower limb ischemia.

Gu YQ, Zhang J, Guo LR, Qi LX, Zhang SW, Xu J, Li JX, Luo T, Ji BX, Li XF, Yu HX, Cui SJ, Wang ZG.

Chin Med J (Engl). 2008 Jun 5;121(11):963-7.

PMID:
18706241
12.

[Autologous bone-marrow stem-cell transplantation for induction of arteriogenesis for limb salvage in critical limb ischaemia].

Amann B, Lüdemann C, Ratei R, Schmidt-Lucke JA.

Zentralbl Chir. 2009 Aug;134(4):298-304. doi: 10.1055/s-0029-1224532. Epub 2009 Aug 17. German.

PMID:
19688676
13.

Application of autologous bone marrow mononuclear cells in six patients with advanced chronic critical limb ischemia as a result of diabetes: our experience.

Subrammaniyan R, Amalorpavanathan J, Shankar R, Rajkumar M, Baskar S, Manjunath SR, Senthilkumar R, Murugan P, Srinivasan VR, Abraham S.

Cytotherapy. 2011 Sep;13(8):993-9. doi: 10.3109/14653249.2011.579961. Epub 2011 Jun 15.

PMID:
21671823
14.

Analysis of possible factors relating to prognosis in autologous peripheral blood mononuclear cell transplantation for critical limb ischemia.

Sun L, Wu L, Qiao Z, Yu J, Li L, Li S, Liu Q, Hu Y, Xu N, Huang P.

Cytotherapy. 2014 Aug;16(8):1110-6. doi: 10.1016/j.jcyt.2014.03.007. Epub 2014 May 15.

PMID:
24834816
15.

A randomized, controlled study of autologous therapy with bone marrow-derived aldehyde dehydrogenase bright cells in patients with critical limb ischemia.

Perin EC, Silva G, Gahremanpour A, Canales J, Zheng Y, Cabreira-Hansen MG, Mendelsohn F, Chronos N, Haley R, Willerson JT, Annex BH.

Catheter Cardiovasc Interv. 2011 Dec 1;78(7):1060-7. doi: 10.1002/ccd.23066. Epub 2011 May 18.

PMID:
21594960
16.

Autologous bone marrow stem cell transplantation in patients with end-stage chronical critical limb ischemia and diabetic foot.

Procházka V, Gumulec J, Chmelová J, Klement P, Klement GL, Jonszta T, Czerný D, Krajca J.

Vnitr Lek. 2009 Mar;55(3):173-8.

PMID:
19378841
18.

Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia.

Ruiz-Salmeron R, de la Cuesta-Diaz A, Constantino-Bermejo M, Pérez-Camacho I, Marcos-Sánchez F, Hmadcha A, Soria B.

Cell Transplant. 2011;20(10):1629-39. doi: 10.3727/096368910X0177.

PMID:
22289660
19.

Intramuscular or combined intramuscular/intra-arterial administration of bone marrow mononuclear cells: a clinical trial in patients with advanced limb ischemia.

Van Tongeren RB, Hamming JF, Fibbe WE, Van Weel V, Frerichs SJ, Stiggelbout AM, Van Bockel JH, Lindeman JH.

J Cardiovasc Surg (Torino). 2008 Feb;49(1):51-8.

PMID:
18212687
20.

Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.

Durdu S, Akar AR, Arat M, Sancak T, Eren NT, Ozyurda U.

J Vasc Surg. 2006 Oct;44(4):732-9. Epub 2006 Aug 22.

Items per page

Supplemental Content

Write to the Help Desk